 |
|
|
|||||
Fans of the Homeworld franchise won't be seeing its new entry arrive this year after all. The long-awaited sequel to Homeworld 2, a sci-fi real-time strategy video game released way back in 2003, was supposed to come out in 2022 before its release was pushed back to the first half of this year. Now, its developer Blackbird Interactive and Gearbox Publishing have revealed that they're moving Homeworld 3's launch date to February 2024. In their announcement, they said that they want to deliver a game that "lives up to the standards set by its predecessors. They continued that in order to fully realize their vision, they need more time to refine and polish the game. Fans' reactions to the announcement on Twitter have been positive so far, with most of them supporting the companies for taking the time to get it right. Upon being asked about the collector's edition they sold, they said those who purchased the box will still receive it at launch. We are moving the launch of Homeworld 3 from the first half of 2023 to February 2024 so that we deliver the quality experience that fans deserve. pic.twitter.com/DaCX4eFMm4 Homeworld (@HomeworldGame) May 25, 2023The companies also posted an extended version of their announcement on Gearbox's website, where they explained that Blackbird's move to implement a four-day work week back in 2022 isn't the reason why the game's release date has been pushed back again. "In fact," they added, "the team is able to achieve as much if not more when given the additional personal time." They didn't go through any technical hurdles and change the scope of the game either it just simply takes time to create and polish a whole game. For fans who can't wait to see how the development is going along, they promised to share their "biggest Homeworld 3 progress update yet later this summer."This article originally appeared on Engadget at https://www.engadget.com/sci-fi-strategy-game-homeworld-3-has-been-delayed-to-february-2024-061237843.html?src=rss
Category:
Marketing and Advertising
Spotted by: Stijn Janssen Image: Nick Koole
Category:
Marketing and Advertising
Turns out Elon Musk's FDA prediction was only off by about a month. After reportedly denying the company's overtures in March, the FDA approved Neuralink's application to begin human trials of its prototype Link brain-computer interface (BCI) on Thursday. Founded in 2016, Neuralink aims to commercialize BCIs in wide-ranging medical and therapeutic applications from stroke and spinal cord injury (SCI) rehabilitation, to neural prosthetic controls, to the capacity "to rewind memories or download them into robots," Neuralink CEO Elon Musk promised in 2020. BCIs essentially translate the analog electrical impulses of your brain (monitoring it using hair-thin electrodes delicately threaded into that grey matter) into the digital 1's and 0's that computers understand. Since that BCI needs to be surgically installed in a patient's noggin, the FDA which regulates such technologies requires that companies conduct rigorous safety testing before giving its approval for commercial use. In March, the FDA rejected Neuralink's application to begin human trials reportedly in part due to all the test animals that kept dying after having the prototype BCI implanted. According to internal documents acquired by Reuters in December, more than 1,500 animals had been killed in the development of the Neuralink BCI since 2018. The US Department of Agriculture's (USDA) Inspector General has since launched an investigation into those allegations. The FDA's reticence was also born from concerns about the design and function of the interface when implanted in humans. "The agencys major safety concerns involved the devices lithium battery; the potential for the implants tiny wires to migrate to other areas of the brain; and questions over whether and how the device can be removed without damaging brain tissue," current and former Neuralink employees told Reuters in March.While Neuralink has obtained FDA approval to begin its study, the company is not yet seeking volunteers. This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people," Neuralink Tweeted on Thursday. "Recruitment is not yet open for our clinical trial." This article originally appeared on Engadget at https://www.engadget.com/neuralink-receives-fda-clearance-to-begin-human-trials-of-its-brain-computer-interface-001504243.html?src=rss
Category:
Marketing and Advertising
All news |
||||||||||||||||||
|
||||||||||||||||||